NO311976B1 - Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering - Google Patents

Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering Download PDF

Info

Publication number
NO311976B1
NO311976B1 NO19984836A NO984836A NO311976B1 NO 311976 B1 NO311976 B1 NO 311976B1 NO 19984836 A NO19984836 A NO 19984836A NO 984836 A NO984836 A NO 984836A NO 311976 B1 NO311976 B1 NO 311976B1
Authority
NO
Norway
Prior art keywords
benzisoxazol
benzenemethanamine
phenyl
formula
solution
Prior art date
Application number
NO19984836A
Other languages
English (en)
Norwegian (no)
Other versions
NO984836L (no
NO984836D0 (no
Inventor
Dirk Casimir Maria Leysen
Gerardus Stephanus Franc Ruigt
Joannes Theodorus Mari Linders
Fredericus Antonius Dijcks
Simon James Anthony Grove
Duncan Robertson Rae
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO984836D0 publication Critical patent/NO984836D0/no
Publication of NO984836L publication Critical patent/NO984836L/no
Publication of NO311976B1 publication Critical patent/NO311976B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO19984836A 1996-04-19 1998-10-16 Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering NO311976B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201065 1996-04-19
PCT/EP1997/001904 WO1997040027A1 (en) 1996-04-19 1997-04-15 Substituted benzylamines and their use for the treatment of depression

Publications (3)

Publication Number Publication Date
NO984836D0 NO984836D0 (no) 1998-10-16
NO984836L NO984836L (no) 1998-12-16
NO311976B1 true NO311976B1 (no) 2002-02-25

Family

ID=8223896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984836A NO311976B1 (no) 1996-04-19 1998-10-16 Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering

Country Status (25)

Country Link
EP (1) EP0898566B1 (ja)
JP (1) JP4008033B2 (ja)
CN (1) CN1139580C (ja)
AR (1) AR006719A1 (ja)
AT (1) ATE227278T1 (ja)
AU (1) AU725847B2 (ja)
BR (1) BR9708790A (ja)
CA (1) CA2251820C (ja)
CZ (1) CZ295747B6 (ja)
DE (1) DE69716896T2 (ja)
DK (1) DK0898566T3 (ja)
ES (1) ES2186888T3 (ja)
HK (1) HK1018271A1 (ja)
HU (1) HU224637B1 (ja)
ID (1) ID17723A (ja)
IL (1) IL120669A (ja)
NO (1) NO311976B1 (ja)
NZ (1) NZ332334A (ja)
PL (1) PL192561B1 (ja)
PT (1) PT898566E (ja)
RU (1) RU2179553C2 (ja)
TR (1) TR199802104T2 (ja)
TW (1) TW498070B (ja)
WO (1) WO1997040027A1 (ja)
ZA (1) ZA973209B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2001019821A1 (en) * 1999-09-14 2001-03-22 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
GB0321538D0 (en) 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
EP1925305A1 (en) * 2006-10-23 2008-05-28 N.V. Organon Ih channel inhibitors for the promotion of wakefulness
US8013165B2 (en) 2008-12-24 2011-09-06 Astrazeneca Ab Ethanamine compounds and methods of using the same 545
US8637551B2 (en) 2009-07-07 2014-01-28 Merck Sharp & Dohme B.V. 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
CN102942464B (zh) * 2012-12-06 2015-04-08 西北师范大学 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法
GB202103012D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103008D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103017D0 (en) 2021-03-03 2021-04-14 King S College London Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO984836L (no) 1998-12-16
CZ295747B6 (cs) 2005-10-12
WO1997040027A1 (en) 1997-10-30
HUP9901434A3 (en) 2001-11-28
HUP9901434A2 (hu) 1999-08-30
RU2179553C2 (ru) 2002-02-20
DK0898566T3 (da) 2003-03-03
CA2251820C (en) 2007-03-27
TR199802104T2 (xx) 2000-09-21
NZ332334A (en) 2000-06-23
ID17723A (id) 1998-01-22
TW498070B (en) 2002-08-11
EP0898566A1 (en) 1999-03-03
CN1139580C (zh) 2004-02-25
CA2251820A1 (en) 1997-10-30
HU224637B1 (hu) 2005-12-28
BR9708790A (pt) 1999-08-03
PL192561B1 (pl) 2006-11-30
PT898566E (pt) 2003-03-31
IL120669A0 (en) 1997-08-14
ES2186888T3 (es) 2003-05-16
PL329348A1 (en) 1999-03-29
AU725847B2 (en) 2000-10-19
ZA973209B (en) 1997-11-20
EP0898566B1 (en) 2002-11-06
DE69716896T2 (de) 2003-07-24
JP4008033B2 (ja) 2007-11-14
IL120669A (en) 2001-04-30
ATE227278T1 (de) 2002-11-15
CN1219169A (zh) 1999-06-09
HK1018271A1 (en) 1999-12-17
NO984836D0 (no) 1998-10-16
AR006719A1 (es) 1999-09-08
CZ334998A3 (cs) 1999-06-16
JP2000508672A (ja) 2000-07-11
DE69716896D1 (de) 2002-12-12
AU2387097A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
NO311976B1 (no) Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering
JP5271903B2 (ja) オピオイド受容体系に作用する、4−ヘテロアリール置換された1−アミノシクロヘキサン−1−及びシクロヘキセン−1−誘導体
WO2007063385A2 (en) Spirocyclic amine histamine-3 receptor antagonists
AU747040B2 (en) Arylpiperazines having activity at the serotonin 1A receptor
CA2438596C (en) Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
HUE025381T2 (en) Compounds for the inhibition of SSAO / VAP-1 and their use for the treatment and prevention of diseases
MXPA03008117A (es) Derivados heterociclicos para el tratamiento del cancer y otras enfermedades proliferativas.
JP6062948B2 (ja) V1aアンタゴニストとしてのシクロヘキシル−4H,6H−5−オキサ−2,3,10b−トリアザ−ベンゾ[e]アズレン
US5079246A (en) Novel indoloquinlones
SK17482000A3 (sk) Antivírusové zlúčeniny, spôsob inhibície vírusov a farmaceutický prípravok
US20060094719A1 (en) Tetralin histamine-3 receptor antagonists
US6080773A (en) Benzylamine derivatives which are useful in treating psychiatric disorders
US20050282811A1 (en) Diazabicyclic histamine-3 receptor antagonists
KR20190084270A (ko) Ror 감마 조정제로서의 트리시클릭 술폰
AU692862B2 (en) Aryl and heteroaryl alkoxynaphthalene derivatives
KR100498823B1 (ko) 치환된벤질아민및이를우울증의치료에사용한방법
Hassner et al. Cycloadditions. 48. Novel heterocycles by bis heteroannulation of oxazoles
US20020037885A1 (en) Therapeutic compounds
EP2504324A1 (en) Sultam derivatives
JP4339939B2 (ja) テトラヒドロイミダゾ〔2,1−a〕イソキノリン誘導体
Bös et al. Synthesis of rel‐(3RS, 3aSR, 7aSR)‐3‐(4‐Chlorophenyl)‐3a, 4, 5, 6, 7, 7a‐hexahydro‐1‐methylindolin‐6‐one, the Main Metabolite of the Analgesic Ro 15‐8081: A Potent Amine‐Uptake Inhibitor
Skorcz et al. 2, 1‐benzisothiazoline 2, 2‐dioxide. I. Some 3‐substituted derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees